TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DENDREON TARGETING CANCER, TRANSFORMING LIVES

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

DENDREON TARGETING CANCER, TRANSFORMING LIVES

ST13

US500000090243305

Classe

5

Pedido

90243305

Registro

6408192

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

20

Atualização mais recente

06/07/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

08/10/2020

Data de registro

06/07/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

06/07/2021

Última transação

06/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Primeiro uso

29/04/2010

Primeiro uso no comércio

29/04/2010

Código do desenho

3

Tipo de titular

16

Localização do titular

Seal Beach, CA, US

Examinador

HOWARD, PARKER WALDRIP

Unidade examinadora

M80

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.

Titulares e representantes

Titulares

Dendreon Pharmaceuticals LLC

Representantes

Diane L. Gardner MASTERMIND IP LAW P.C.

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

20 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/07/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/12/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/12/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/12/2024

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

04/12/2024

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

04/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/04/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

20/04/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

20/04/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

06/07/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

20/04/2021

PUBO

PUBLISHED FOR OPPOSITION

20/04/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

31/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/03/2021

DOCK

ASSIGNED TO EXAMINER

08/03/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

25/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/11/2020

NWAP

NEW APPLICATION ENTERED

12/10/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DENDREON TARGETING CANCER, TRANSFORMING LIVES ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.